Compare EVO & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | ASTE |
|---|---|---|
| Founded | 1993 | 1972 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 991.0M |
| IPO Year | 2021 | N/A |
| Metric | EVO | ASTE |
|---|---|---|
| Price | $3.65 | $47.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 251.6K | 199.3K |
| Earning Date | 11-05-2025 | 02-25-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.08 |
| Revenue | $887,396,457.00 | ★ $1,368,800,000.00 |
| Revenue This Year | N/A | $8.19 |
| Revenue Next Year | $8.52 | $6.23 |
| P/E Ratio | ★ N/A | $22.22 |
| Revenue Growth | N/A | ★ 6.66 |
| 52 Week Low | $2.84 | $29.65 |
| 52 Week High | $4.80 | $50.83 |
| Indicator | EVO | ASTE |
|---|---|---|
| Relative Strength Index (RSI) | 71.06 | 58.90 |
| Support Level | $3.10 | $43.20 |
| Resistance Level | $3.23 | $47.77 |
| Average True Range (ATR) | 0.08 | 1.32 |
| MACD | 0.08 | 0.19 |
| Stochastic Oscillator | 96.87 | 96.06 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.